Emerging Markets Earnings Roundup: Bayer (Part 8)
This article was originally published in PharmAsia News
Executive Summary
Bayer saw 40% of its revenues come from emerging markets in the fourth quarter of 2013. The health care business unit lagged in Asia for the year, but the company expects rapid growth in China through acquisitions and other expansion plans.